U.S. markets open in 3 hours 49 minutes
  • S&P Futures

    4,163.25
    +0.75 (+0.02%)
     
  • Dow Futures

    33,955.00
    +32.00 (+0.09%)
     
  • Nasdaq Futures

    13,987.75
    -26.25 (-0.19%)
     
  • Russell 2000 Futures

    2,261.00
    +5.30 (+0.23%)
     
  • Crude Oil

    63.66
    +0.20 (+0.32%)
     
  • Gold

    1,766.90
    +0.10 (+0.01%)
     
  • Silver

    26.00
    +0.04 (+0.14%)
     
  • EUR/USD

    1.1980
    +0.0004 (+0.04%)
     
  • 10-Yr Bond

    1.5300
    0.0000 (0.00%)
     
  • Vix

    16.64
    -0.35 (-2.06%)
     
  • GBP/USD

    1.3766
    -0.0019 (-0.14%)
     
  • USD/JPY

    108.8300
    +0.1140 (+0.10%)
     
  • BTC-USD

    60,885.22
    -1,884.23 (-3.00%)
     
  • CMC Crypto 200

    1,346.85
    -34.10 (-2.47%)
     
  • FTSE 100

    7,021.16
    +37.66 (+0.54%)
     
  • Nikkei 225

    29,683.37
    +40.68 (+0.14%)
     

Elekta divests its stake in ViewRay

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction.

The shares in ViewRay were purchased in a public offering in December 2019 at USD 3.13 per share and sold today at USD 4.65 per share. The proceeds from the sale were approximately USD 53 million, resulting in a gain of approximately USD 17.5 million. The gain will be booked in Elekta's third quarter 2020/21.

For further information, please contact:

Mattias Thorsson, VP Corporate Communications
Tel: +46 70 865 8012
e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time

Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25
e-mail: cecilia.ketels@elekta.com
Time zone: CET: Central European Time

This is information that Elekta AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 07:30 CET on January 22, 2021. (REGMAR)

About Elekta

For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to - and benefits from - more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/elekta/r/elekta-divests-its-stake-in-viewray,c3272256

The following files are available for download: